You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Keytruda

Showing 1 - 25 of 945
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial (GME751, Keytruda - EU, Keytruda - US)

Not yet recruiting
  • Melanoma
  • (no location specified)
Nov 22, 2023

Healthy Male Subjects Trial (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection, Pembrolizumab

Not yet recruiting
  • Healthy Male Subjects
  • Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection
  • Pembrolizumab injection
  • (no location specified)
Oct 30, 2023

Melanoma (Skin) Trial in Omsk, Saint Petersburg (BCD-201, Keytruda)

Recruiting
  • Melanoma (Skin)
  • Omsk, Russian Federation
  • +2 more
Aug 1, 2023

Non Small Cell Lung Cancer Metastatic Trial (Pembrolizumab, Pembrolizumab biosimilar)

Not yet recruiting
  • Non Small Cell Lung Cancer Metastatic
  • (no location specified)
Dec 19, 2022

Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,

Not yet recruiting
  • Biliary Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
May 13, 2023

Melanoma, Non Small Cell Lung Cancer Trial in Moscow, Omsk, Saint Petersburg (BCD-201, Keytruda)

Active, not recruiting
  • Melanoma
  • Non Small Cell Lung Cancer
  • Moscow, Russian Federation
  • +2 more
Feb 13, 2023

Gastric and Gastroesophageal Junction Adenocarcinoma Trial (Pembrolizumab (Keytruda®), Trifluridine/Tipiracil (Lonsurf®))

Not yet recruiting
  • Gastric and Gastroesophageal Junction Adenocarcinoma
  • Pembrolizumab (Keytruda®), Trifluridine/Tipiracil (Lonsurf®)
  • (no location specified)
Aug 17, 2022

Gastric Cancer, Hepatocellular Carcinoma Trial in Beverly Hills, Los Angeles, Torrance (Telatinib, Keytruda)

Recruiting
  • Gastric Cancer
  • Hepatocellular Carcinoma
  • Beverly Hills, California
  • +3 more
Sep 1, 2022

Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)

Active, not recruiting
Has Results
  • Kidney Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 21, 2022

Metastatic Renal Cell Carcinoma Trial in United Kingdom (Cyclophosphamide 50mg, Pembrolizumab 25 mg/1 ML Intravenous Solution

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Cyclophosphamide 50mg
  • Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA]
  • Cambridge, United Kingdom
  • +3 more
Aug 22, 2022

GBM Trial (Lenvatinib, Pembrolizumab, Tumor Treating Fields (TTFields))

Not yet recruiting
  • GBM
  • (no location specified)
Aug 2, 2023

Hepatocellular Carcinoma Trial (Pembrolizumab)

Active, not recruiting
Has Results
  • Hepatocellular Carcinoma
  • Pembrolizumab
  • (no location specified)
Dec 15, 2022

Advanced Melanoma Trial in Pittsburgh (Pembrolizumab Injection [Keytruda], Metformin)

Recruiting
  • Advanced Melanoma
  • Pittsburgh, Pennsylvania
    Univ of Pittsburgh Medical Center Hillman Cancer Center
Jan 24, 2022

Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose

Not yet recruiting
  • Cancer
  • +16 more
  • KVA12123 - Dose Escalation
  • +3 more
  • (no location specified)
Feb 2, 2023

Urothelial Cancer Trial (pembrolizumab)

Completed
Has Results
  • Urothelial Cancer
  • pembrolizumab
  • (no location specified)
Aug 18, 2022

Adenoid Cystic Carcinoma Trial in Boston (Radiation, Pembrolizumab)

Completed
Has Results
  • Adenoid Cystic Carcinoma
  • Boston, Massachusetts
  • +1 more
Oct 8, 2022

Advanced Biliary Tract Carcinoma Trial in Shanghai (Pembrolizumab Injection [Keytruda], Lenvatinib Mesylate)

Recruiting
  • Advanced Biliary Tract Carcinoma
  • Pembrolizumab Injection [Keytruda]
  • Lenvatinib Mesylate
  • Shanghai, Shanghai, China
  • +1 more
Jul 19, 2022

Advanced Hepatocellular Carcinoma Trial (Tegavivint, Pembrolizumab)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • (no location specified)
Mar 21, 2023

Advanced Solid Tumors Trial (AMG 355, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Nov 9, 2023

Biliary Tract Cancer Trial (GEN-001, Pembrolizumab, mFOLFOX)

Not yet recruiting
  • Biliary Tract Cancer
  • (no location specified)
Aug 16, 2023

Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

Not yet recruiting
  • Papillary Renal Cell Carcinoma
  • (no location specified)
Nov 24, 2023

Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Residual Disease
  • (no location specified)
Nov 15, 2023

Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)

Not yet recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    SKCCC Johns Hopkins
Aug 16, 2023

Malignant Ascites Trial in Taichung (Nivolumab, Pembrolizumab)

Enrolling by invitation
  • Malignant Ascites
  • Taichung, Please Select, Taiwan
    China Medical University Hospital
Feb 16, 2023

Colorectal Cancer Trial (Pembrolizumab)

Recruiting
  • Colorectal Cancer
  • Amsterdam, Netherlands
    Netherlands Cancer Institute
Jan 3, 2023